Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewAn example of collaboration to catch pancreatic cancer as early as possible
Amadix, IOMED and NorayBio have joined forces to develop a predictive algorithm for mass data analysis to reduce the mortality rate of this disease
-
OfferInvestigador/a
-
-
-
-
Offer
Investigador/a
-
-
NewGENESIS Biomed sponsors ITEMAS 2022 Annual Conference Day
The “Instituto de Investigación Biomédica de Córdoba” hosts the event, supported by “Instituto de Salud Carlos III (ISCIII)”, with the sponsorship of “Universidad Carlos III de Madrid”, Cidi Salud and
-
NewAptaTargets awarded €2.5 million grant from Spanish government to evaluate ApTOLL for acut...
The funds are from a competitive call through the 2021 State Programme to Promote Scientific-Technical Research and its Transfer (formerly known as Retos Colaboración).
-
-
-
EventTransfiere 2023
AseBio will play a leading role in Transfiere 2023 with talks and a stand next month in Malaga to showcase the work of biotechnology for the green transition.
-
EventUn día con una #MujerBiotech
AseBio lanza el primer programa para emparejar mujeres estudiantes y profesionales 'biotech' con motivo del Día Mundial de la Mujer y la Niña en la Ciencia que se celebra el 1
-
-
NewCellab CDMO, Cellab's new activity
The Andorran biotech company is working to obtain Good Manufacturing Practices (GMP) during the first half of 2023
-
NewYsios Capital strengthens its team with internal promotions and a new Venture Partner
Jordi Xiol has been promoted to Partner after joining Ysios Capital in 2019 Ysios is also incorporating Sanifit co-founder and CEO Joan Perelló as Venture Partner
-
NewBCN HEALTH has published 10 studies in 2022 assessing the incidence and costs of illness o...
BCN HEALTH has published 10 studies in 2022 assessing the incidence and cost of illness of different diseases in Spain.
-
NewDIVERSA Technologies is driven by Innovation
The Galician Innovation Agency has awarded DIVERSA through the InnovaPeme program to implement its innovation plan in 2022 and 2023
-
-
NewThe first orally administered biologic medicine based on intestinal microbiota: fiction or...
Mikrobiomik aims to be the first company in the world to commercialize the first biologic medicine based on intestinal microbiota, in primary or recurrent Clostridiodes difficile infection
-
NewLa biotech española Laminar Pharma alcanza la cifra de 45 pacientes reclutados en el ensay...
Laminar Pharmaceuticals S.A., se complace en anunciar el reclutamiento de los primeros 45 pacientes en el estudio clínico de fase II/III en glioblastoma de nuevo diagnóstico
